News
MEDIF
0.052
0.00%
0.000
Weekly Report: what happened at MEDIF last week (0601-0605)?
Weekly Report · 1d ago
Weekly Report: what happened at MEDIF last week (0525-0529)?
Weekly Report · 06/01 10:25
MediPharm Labs announces upcoming annual and special shareholder meeting
PUBT · 05/28 12:07
Weekly Report: what happened at MEDIF last week (0518-0522)?
Weekly Report · 05/25 10:29
Weekly Report: what happened at MEDIF last week (0511-0515)?
Weekly Report · 05/18 10:28
MediPharm Labs Earnings Call Balances Pressure And Promise
TipRanks · 05/14 00:45
Transcript: MediPharm Labs Q1 2026 Earnings Conference Call
Benzinga · 05/13 14:30
MediPharm Labs Q1 EPS US$0.00, Sales US$6.535M Down From US$7.528M YoY
Benzinga · 05/13 11:42
Canada's MediPharm Labs reports positive Q1 adjusted EBITDA
Reuters · 05/13 11:41
MediPharm Labs reports Q1 results
Seeking Alpha · 05/13 11:34
MediPharm Labs Q1 FY26 adjusted EBITDA turns positive to $103,000; revenue falls to $9 million
PUBT · 05/13 11:31
MEDIPHARM LABS REPORTS FIRST QUARTER 2026 RESULTS ACHIEVING POSITIVE ADJUSTED EBITDA
Reuters · 05/13 11:30
MEDIPHARM LABS Q1 REVENUE CAD 9 MILLION
Reuters · 05/13 11:30
Stocks in play: MediPharm Labs Corp.
Barchart · 05/13 10:06
Here are the major earnings before the open Wednesday
Seeking Alpha · 05/12 22:00
Weekly Report: what happened at MEDIF last week (0504-0508)?
Weekly Report · 05/11 10:25
MediPharm Labs updates financial calendar for first-quarter results release and investor call
PUBT · 05/08 00:05
MediPharm Labs Sets Date to Report First Quarter 2026 Financial Results
Barchart · 05/07 19:05
Weekly Report: what happened at MEDIF last week (0427-0501)?
Weekly Report · 05/04 10:23
MediPharm Labs welcomes US cannabis rescheduling to Schedule III, cites clinical trial supply readiness
PUBT · 04/27 12:31
More
Webull provides a variety of real-time MEDIF stock news. You can receive the latest news about Medipharm Labs Corp through multiple platforms. This information may help you make smarter investment decisions.
About MEDIF
MediPharm Labs Corp. is a Canada-based pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. It develops, formulates, processes, packages and distributes cannabis and advanced cannabinoid-based products to domestic and international medical markets. The Company cultivates and processes cannabis to sell as dried flower, pre-roll and other cannabis products for adult use, medical, and international markets. The Company also provides GMP flower sourcing, packaging, and distribution services for select international clients. Its wholly owned subsidiary Harvest Medicine Inc. operates medical clinics in Canada that provide medical cannabis patients with physician consultations for medical cannabis education and prescriptions. Its international subsidiaries include Beacon Medical Germany GmbH and Beacon Medical Australia Pty Ltd.